Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage - PubMed (original) (raw)
doi: 10.1159/000455983. Epub 2017 Jan 18.
- PMID: 28214828
- DOI: 10.1159/000455983
Free article
Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage
Jie-Ping Wang et al. Cell Physiol Biochem. 2017.
Free article
Abstract
Background/aims: Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase and activation of its signal pathway plays an important role in regulating protein growth and synthesis as well as cell proliferation and survival. In the present study, we examined the contribution of mTOR signal and its downstream products to brain injuries induced by intracerebral hemorrhage (ICH) in rats.
Methods: Western Blot analysis was employed to examine the protein expression of mTOR and its downstream pathway and Caspase-3. ELISA was used to measure pro-inflammatory cytokines (PICs) and vascular endothelial growth factor (VEGF). Additionally, neurological Severity Score and brain water content were used to indicate neurological function and brain edema.
Results: The protein expression of p-mTOR, mTOR-mediated phosphorylation of 4E-binding protein 4 (4E-BP1), p70 ribosomal S6 protein kinase 1 (S6K1) pathways were amplified in ICH rats compared with controls. Blocking mTOR using rapamycin significantly attenuated upregulation of PICs, namely IL-1β, IL-6 and TNF-α, and Caspase-3 indicating cell apoptosis, and promoted the levels of VEGF and its subtype receptor VEGFR-2 in brain tissues. Moreover, the effects of rapamycin were linked to improvement of neurological deficits and increased brain water content observed in ICH rats.
Conclusion: Activation mTOR signal is engaged in pathophysiological process during ICH and blocking mTOR pathway plays a beneficial role in regulating neuronal tissues via PIC, apoptotic Caspase-3 and VEGF mechanisms. This has pharmacological implications to target specific mTOR and its downstream signal pathway for neuronal dysfunction and vulnerability related to ICH.
Keywords: Caspase-3; Cytokines; Intracerebral hemorrhage; Rapamycin; mTOR.
© 2017 The Author(s) Published by S. Karger AG, Basel.
Similar articles
- Role for HIF-1α and Downstream Pathways in Regulating Neuronal Injury after Intracerebral Hemorrhage in Diabetes.
Yu Z, Tang L, Chen L, Li J, Wu W, Hu C. Yu Z, et al. Cell Physiol Biochem. 2015;37(1):67-76. doi: 10.1159/000430334. Epub 2015 Aug 12. Cell Physiol Biochem. 2015. PMID: 26278717 - Effects of mTOR on Neurological Deficits after Transient Global Ischemia.
Xing J, Lu J. Xing J, et al. Transl Neurosci. 2017 Apr 30;8:21-26. doi: 10.1515/tnsci-2017-0005. eCollection 2017. Transl Neurosci. 2017. PMID: 28729914 Free PMC article. - Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy.
Wei J, Jiang H, Gao H, Wang G. Wei J, et al. Cell Physiol Biochem. 2016;40(6):1570-1577. doi: 10.1159/000453207. Epub 2016 Dec 21. Cell Physiol Biochem. 2016. PMID: 27997905 - Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.
Chong ZZ, Shang YC, Zhang L, Wang S, Maiese K. Chong ZZ, et al. Oxid Med Cell Longev. 2010 Nov-Dec;3(6):374-91. doi: 10.4161/oxim.3.6.14787. Epub 2010 Nov 1. Oxid Med Cell Longev. 2010. PMID: 21307646 Free PMC article. Review. - The role of mTOR signaling pathway in spinal cord injury.
Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Tateda S, Yahata K, Itoi E. Kanno H, et al. Cell Cycle. 2012 Sep 1;11(17):3175-9. doi: 10.4161/cc.21262. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22895182 Free PMC article. Review.
Cited by
- FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O, Elgokhy T, Do T, Gann M, Martin R, Liu DZ. Lui A, et al. Pharmaceuticals (Basel). 2022 Dec 13;15(12):1546. doi: 10.3390/ph15121546. Pharmaceuticals (Basel). 2022. PMID: 36558997 Free PMC article. Review. - Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.
Burillo J, Marqués P, Jiménez B, González-Blanco C, Benito M, Guillén C. Burillo J, et al. Cells. 2021 May 18;10(5):1236. doi: 10.3390/cells10051236. Cells. 2021. PMID: 34069890 Free PMC article. Review. - Systematic Understanding of Mechanism of Yi-Qi-Huo-Xue Decoction Against Intracerebral Hemorrhagic Stroke Using a Network Pharmacology Approach.
Li J, Ye M, Gao J, Zhang Y, Zhu Q, Liang W. Li J, et al. Med Sci Monit. 2020 Aug 8;26:e921849. doi: 10.12659/MSM.921849. Med Sci Monit. 2020. PMID: 32769962 Free PMC article. - Acute Inflammation in Cerebrovascular Disease: A Critical Reappraisal with Focus on Human Studies.
Dias RA, Dias L, Azevedo E, Castro P. Dias RA, et al. Life (Basel). 2021 Oct 17;11(10):1103. doi: 10.3390/life11101103. Life (Basel). 2021. PMID: 34685473 Free PMC article. Review. - Pro-BDNF Contributes to Hypoxia/Reoxygenation Injury in Myocardial Microvascular Endothelial Cells: Roles of Receptors p75NTR and Sortilin and Activation of JNK and Caspase 3.
Yu F, Liu Y, Xu J. Yu F, et al. Oxid Med Cell Longev. 2018 Jun 26;2018:3091424. doi: 10.1155/2018/3091424. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30046375 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous